{"lastName":"Fang","objectUrn":"urn:li:member:123278221","geoRegion":"Cambridge, Massachusetts, United States","fullName":"Tao Fang","firstName":"Tao","currentPositions":[{"companyName":"Flagship Pioneering","description":"Innovation, Strategy, Operation, Investment\n-Ampersand Biomedicines\n-Profound Therapeutics","title":"Senior Associate","companyUrnResolutionResult":{"employeeCountRange":"201-500","headquarters":{"geographicArea":"MA","country":"United States","city":"Cambridge","postalCode":"02142","line2":"Suite 800E","line1":"55 Cambridge Parkway"},"website":"http:\/\/www.flagshippioneering.com","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/flagship-pioneering\/","industry":"Biotechnology Research"},"companyUrn":"urn:li:fs_salesCompany:29602","tenureAtCompany":{"numYears":3,"numMonths":5},"startedOn":{"year":2022}}],"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdZE40BzwNhFntdufxr9f1Grez_gnhI4Og,NAME_SEARCH,HjmA)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1651892748829?e=1723075200&v=beta&t=XZJvnwllVplOCiHt0QOBu11OrUHQoKzcOENWzjuFdHE","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1651892748829?e=1723075200&v=beta&t=rs34Rha9eImg9-MnFLYCLyJmiK3I4dfkBaHq81RUiBQ","height":200},{"width":400,"fileIdentifyingUrlPathSegment":"400_400\/0\/1651892748829?e=1723075200&v=beta&t=Hb95atVyj_Y9IiAig4b8sKEq0xRS8ipFElIALwBlMhA","height":400},{"width":800,"fileIdentifyingUrlPathSegment":"800_800\/0\/1651892748829?e=1723075200&v=beta&t=jvL4QQK7HNBFS9SqMX4_Mvonp3aPUMuNruRDeRrtSxA","height":800}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/C4E03AQFKw9WL3T1d9w\/profile-displayphoto-shrink_"},"projects":[],"contactInfo":{},"industry":"Biotechnology Research","educations":[{"endedOn":{"year":2025},"degree":"Master of Business Administration - MBA","schoolUrn":"urn:li:fs_salesSchool:3157","eduId":893980468,"school":"urn:li:fs_salesSchool:3157","schoolName":"NYU Stern School of Business"},{"endedOn":{"year":2019},"degree":"Postdoctoral Fellowship","eduId":641963498,"schoolUrn":"urn:li:fs_salesSchool:1503","school":"urn:li:fs_salesSchool:1503","fieldsOfStudy":["Chemical Immunology"],"schoolName":"Massachusetts Institute of Technology\/Whitehead Institute","startedOn":{"year":2014}},{"endedOn":{"year":2014},"degree":"Doctor of Philosophy (Ph.D.)","eduId":72649406,"schoolUrn":"urn:li:fs_salesSchool:166638","school":"urn:li:fs_salesSchool:166638","fieldsOfStudy":["Chemistry"],"schoolName":"The University of Georgia","startedOn":{"year":2008}}],"skills":[{"numOfEndorsement":2,"name":"antibody"},{"numOfEndorsement":12,"name":"Biochemistry"},{"numOfEndorsement":9,"name":"Complex oligosaccharide synthesis"},{"numOfEndorsement":3,"name":"Glycopeptide synthesis"},{"numOfEndorsement":0,"name":"Strategic Planning"},{"numOfEndorsement":0,"name":"Project Management"},{"numOfEndorsement":10,"name":"Mass Spectrometry"},{"numOfEndorsement":9,"name":"HPLC"},{"numOfEndorsement":2,"name":"High-Performance Liquid Chromatography (HPLC)"},{"numOfEndorsement":5,"name":"Molecular Biology"},{"numOfEndorsement":11,"name":"NMR"},{"numOfEndorsement":2,"name":"Nuclear Magnetic Resonance (NMR)"},{"numOfEndorsement":4,"name":"Organic Chemistry"},{"numOfEndorsement":7,"name":"Organic Synthesis"},{"numOfEndorsement":1,"name":"Protein Chemistry"},{"numOfEndorsement":3,"name":"Research"}],"numOfConnections":1024,"patents":[],"headline":"Flagship | Venture Creation","courses":[],"certifications":[],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/fspbiotech","organizations":[],"location":"Cambridge, Massachusetts, United States","publications":[{"name":"Site\u2010Specific Protein Labeling via Sortase\u2010Mediated Transpeptidation","publishedOn":{"year":2017},"publisher":"Current protocols in protein science 89 (1), 15.3. 1-15.3. 19","url":"https:\/\/currentprotocols.onlinelibrary.wiley.com\/doi\/abs\/10.1002\/cpps.38","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdZE40BzwNhFntdufxr9f1Grez_gnhI4Og,NAME_SEARCH,HjmA)"}]},{"name":"An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse model","publishedOn":{"year":2017},"publisher":"Scientific reports 7 (1), 252\t","url":"https:\/\/www.nature.com\/articles\/s41598-017-00193-w","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdZE40BzwNhFntdufxr9f1Grez_gnhI4Og,NAME_SEARCH,HjmA)"}]},{"name":"Targeted antigen delivery by an anti-class II MHC VHH elicits focused \u03b1MUC1 (Tn) immunity","publishedOn":{"year":2017},"publisher":"Chemical science 8 (8), 5591-5597\t","url":"http:\/\/pubs.rsc.org\/en\/content\/articlehtml\/2017\/sc\/c7sc00446j","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdZE40BzwNhFntdufxr9f1Grez_gnhI4Og,NAME_SEARCH,HjmA)"}]},{"name":"Mechanism of glycosylation of anomeric sulfonium ions","publisher":"Journal of the American Chemical Society 138 (9), 3002-3011\t","url":"https:\/\/pubs.acs.org\/doi\/abs\/10.1021\/jacs.5b08436","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdZE40BzwNhFntdufxr9f1Grez_gnhI4Og,NAME_SEARCH,HjmA)"}]},{"name":"Structurally Defined \u03b1MHC\u2010II Nanobody\u2013Drug Conjugates: A Therapeutic and Imaging System for B\u2010Cell Lymphoma","publishedOn":{"year":2016},"publisher":"Angewandte Chemie International Edition 55 (7), 2416-2420","url":"https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/anie.201509432","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdZE40BzwNhFntdufxr9f1Grez_gnhI4Og,NAME_SEARCH,HjmA)"}]},{"name":"Fluorophore\u2010Conjugated Holliday Junctions for Generating Super\u2010Bright Antibodies and Antibody Fragments","publishedOn":{"year":2016},"publisher":"Angewandte Chemie International Edition 54 (40), 11706-11710\t","url":"https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/anie.201505277","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdZE40BzwNhFntdufxr9f1Grez_gnhI4Og,NAME_SEARCH,HjmA)"}]},{"name":"Synthesis of Staphylococcus aureus Type 5 Trisaccharide Repeating Unit: Solving the Problem of Lactamization","publishedOn":{"year":2015},"publisher":"Organic letters 17 (4), 928-931","url":"https:\/\/pubs.acs.org\/doi\/abs\/10.1021\/acs.orglett.5b00031","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdZE40BzwNhFntdufxr9f1Grez_gnhI4Og,NAME_SEARCH,HjmA)"}]},{"name":"Preparation of Well\u2010Defined Antibody\u2013Drug Conjugates through Glycan Remodeling and Strain\u2010Promoted Azide\u2013Alkyne Cycloadditions","publishedOn":{"year":2014},"publisher":"Angewandte Chemie 126 (28), 7307-7310","url":"https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/ange.201402606","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdZE40BzwNhFntdufxr9f1Grez_gnhI4Og,NAME_SEARCH,HjmA)"}]},{"name":"Stereoselective assembly of complex oligosaccharides using anomeric sulfonium ions as glycosyl donors","publishedOn":{"year":2012},"publisher":"Journal of the American Chemical Society 134 (17), 7545-7552","url":"https:\/\/pubs.acs.org\/doi\/abs\/10.1021\/ja3018187","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdZE40BzwNhFntdufxr9f1Grez_gnhI4Og,NAME_SEARCH,HjmA)"}]},{"name":"Synthetic, structural, and biosynthetic studies of an unusual phospho-glycopeptide derived from \u03b1-dystroglycan","publishedOn":{"year":2011},"publisher":"Journal of the American Chemical Society 133 (36), 14418-14430","url":"https:\/\/pubs.acs.org\/doi\/abs\/10.1021\/ja205473q","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdZE40BzwNhFntdufxr9f1Grez_gnhI4Og,NAME_SEARCH,HjmA)"}]},{"name":"Progress in the Total Synthesis of Tumor-Associated Carbohydrate Antigen Globo-H Hexasaccharide","publishedOn":{"year":2010},"publisher":"Chinese Journal of Organic Chemistry 30 (1), 38-46","url":"https:\/\/scholar.google.com\/scholar?cluster=3211689994189375758&hl=en&oi=scholarr","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdZE40BzwNhFntdufxr9f1Grez_gnhI4Og,NAME_SEARCH,HjmA)"}]},{"name":"Nanobody immunostaining for correlated light and electron microscopy with preservation of ultrastructure","publishedOn":{"month":11,"day":5,"year":2018},"publisher":"Nature Methods","url":"https:\/\/www.nature.com\/articles\/s41592-018-0177-x","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdZE40BzwNhFntdufxr9f1Grez_gnhI4Og,NAME_SEARCH,HjmA)"}]},{"name":"Remodeling of the Tumor Microenvironment by a Chemokine\/Anti-PD-L1 Nanobody Fusion Protein","publishedOn":{"year":2019},"publisher":"Mol. Pharmaceutics 2019, 16, 6, 2838-2844","url":"https:\/\/pubs.acs.org\/doi\/abs\/10.1021\/acs.molpharmaceut.9b00078","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdZE40BzwNhFntdufxr9f1Grez_gnhI4Og,NAME_SEARCH,HjmA)"}]},{"name":"Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent mice","publishedOn":{"year":2019},"publisher":"PNAS April 16, 2019 116 (16) 7624-7631","url":"https:\/\/www.pnas.org\/content\/116\/16\/7624.short","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdZE40BzwNhFntdufxr9f1Grez_gnhI4Og,NAME_SEARCH,HjmA)"}]},{"name":"Induction of antigen-specific tolerance by nanobody\u2013antigen adducts that target class-II major histocompatibility complexes","publishedOn":{"month":6,"day":14,"year":2021},"publisher":"Nature Biomedical Engineering","url":"https:\/\/www.nature.com\/articles\/s41551-021-00738-5?fbclid=IwAR3psyah4DTyJskPipcEshM3Nt7NcBb35MQvXqZAvxKpjBX7frCxcK_6MkM","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdZE40BzwNhFntdufxr9f1Grez_gnhI4Og,NAME_SEARCH,HjmA)"}]},{"name":"Improved antitumor efficacy of chimeric antigen receptor T cells that secrete single-domain antibody fragments","publishedOn":{"month":4,"day":1,"year":2021},"publisher":"Cancer Immunology Research","url":"https:\/\/cancerimmunolres.aacrjournals.org\/content\/8\/4\/518.abstract","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdZE40BzwNhFntdufxr9f1Grez_gnhI4Og,NAME_SEARCH,HjmA)"}]},{"name":"NATIVE: Nanobody-assisted tissue immunostaining for volumetric EM","publishedOn":{"month":10,"day":17,"year":2018},"publisher":"PROTOCOL EXCHANGE","url":"https:\/\/www.nature.com\/protocolexchange\/protocols\/7039\/uploads\/7145","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdZE40BzwNhFntdufxr9f1Grez_gnhI4Og,NAME_SEARCH,HjmA)"}]},{"name":"Penta-O-benzoyl-D-glucose: an efficient glycosyl donor for the synthesis of a-arbutin and a-aromatic-O-glucosides","publishedOn":{"month":8,"day":1,"year":2009},"authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdZE40BzwNhFntdufxr9f1Grez_gnhI4Og,NAME_SEARCH,HjmA)"}]},{"name":"Generation of immunity against pathogens via single-domain antibody\u2013antigen constructs","publishedOn":{"month":12,"day":15,"year":2016},"publisher":"The Journal of Immunology","url":"https:\/\/www.jimmunol.org\/content\/197\/12\/4838.short","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdZE40BzwNhFntdufxr9f1Grez_gnhI4Og,NAME_SEARCH,HjmA)"}]},{"name":"Multiplexed Volumetric CLEM enabled by antibody derivatives provides new insights into the cytology of the mouse cerebellar cortex","publishedOn":{"month":5,"day":3,"year":2023},"publisher":"bioRxiv","url":"https:\/\/www.biorxiv.org\/content\/10.1101\/2023.05.20.540091v4.abstract","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdZE40BzwNhFntdufxr9f1Grez_gnhI4Og,NAME_SEARCH,HjmA)"}]},{"name":"Probing Molecular Diversity and Ultrastructure of Brain Cells with Fluorescent Aptamers","publishedOn":{"month":9,"day":18,"year":2023},"publisher":"BioRxiv","url":"https:\/\/www.biorxiv.org\/content\/10.1101\/2023.09.18.558240v1","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAdZE40BzwNhFntdufxr9f1Grez_gnhI4Og,NAME_SEARCH,HjmA)"}]}],"positions":null,"posts":[{"createdAt":1716223440000,"insightId":"b4d2bd9e-4f63-4a1a-9eb8-0e1fdf67e110","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":5}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7198362855824343041","threadUrn":"urn:li:activity:7198362855824343041","reactionsCount":5,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7198362855409168384","message":{"attributes":[],"text":"Exciting time at AZ! ADCs manufacturing facility coming up soon"},"rootActivity":{"contentSummaryUnion":{"mediaContentSummary":{"mediaType":"STILLIMAGE","thumnailUrl":"https:\/\/media.licdn.com\/dms\/image\/D4E10AQFW4uKFQl9AkQ\/image-shrink_1280\/0\/1716184882748?e=1717977600&v=beta&t=9PcqWmArShNYY8RpK6hlAYlR5wl1_GGx2YI8oWaC1Gk"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7198201135436840961","message":{"attributes":[{"length":42,"start":328,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:165979"}}},{"length":9,"start":545,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:oncology"}}},{"length":17,"start":555,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:whatsciencecando"}}}],"text":"We are excited to announce our plans for a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs).  ADCs are a class of drugs designed as a targeted therapy for treating cancer.\n\nThis new facility will further enhance our world-class supply chain. The planned greenfield facility, supported by the Singapore Economic Development Board (EDB), will be designed to emit zero carbon from its first day of operations and will be the first end-to-end ADC production site in our global manufacturing and supply network. \n\n#Oncology #WhatScienceCanDo"},"entityUrn":"urn:li:share:7198201135436840961"},"entityUrn":"urn:li:share:7198362855409168384"}}},{"createdAt":1712006520000,"insightId":"19b842eb-8239-4ba8-a9cd-51dae976cc38","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7180585837510696962,7180675986261209090)","threadUrn":"urn:li:ugcPost:7180585837510696962","reactionsCount":0,"commentsCount":1,"canComment":true},"commentary":{"attributes":[{"start":0,"length":5,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:163010096"}}}],"text":"Arnab if you are Ok relocating to MD, contact me. All the best"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7180585837510696962"}}},{"createdAt":1709997360000,"insightId":"78d54b01-d6e1-41d0-afad-e0f31d329668","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7171750034265268224,7172248996516732928)","threadUrn":"urn:li:ugcPost:7171750034265268224","reactionsCount":0,"commentsCount":1,"canComment":true},"commentary":{"attributes":[],"text":"Congratulations Bomi, very well deserved \ud83d\udc4f"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7171750034265268224"}}},{"createdAt":1709655420000,"insightId":"29ac68e0-710b-4b8c-b0b4-cdd9abd593d2","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7170533365199060992,7170814596692328448)","threadUrn":"urn:li:ugcPost:7170533365199060992","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Congratulations Andrew, all the very best! We will miss you here at AZ"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7170533365199060992"}}}]}